European Biotechs Catch US IPO Fever
Biotie Therapies Corp. fine-tuned its initial public offering plans Thursday, making the Finnish central nervous disease treatment developer the latest European life sciences company to push forward with plans to break...To view the full article, register now.
Already a subscriber? Click here to view full article